CE Celanese Corp
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · NYSE · SEC CIK 1306830 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.4%
TTM net income YoY108.4%
TTM EPS YoY108.4%
Revenue 3-yr CAGR-2.8%
Net income 3-yr CAGR-49.5%
Margins
Gross margin20.8%
Operating margin7.9%
Net margin2.7%
FCF margin8.1%
EBITDA margin16.6%
Returns
ROE6.4%
ROA1.2%
ROIC (approx.)4.6%
Asset turnover0.46x
Leverage & solvency
Liabilities / assets77.9%
Debt / equity2.74x
Current ratio1.26x
Interest coverage1.08x
Cash quality & payout
Operating cash flow / net income4.10x
Accruals ratio-3.8%
Payout ratio5.3%
Capex / revenue2.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $9.54B | $10.27B |
| Cost of revenue | $7.59B | $7.93B |
| Gross profit | $1.95B | $2.34B |
| R&D expense | $125.00M | $130.00M |
| SG&A expense | $899.00M | $1.03B |
| Operating income | -$786.00M | -$720.00M |
| Interest expense | $701.00M | $676.00M |
| Pretax income | -$1.22B | -$1.02B |
| Income tax | -$90.00M | $507.00M |
| Net income | -$1.17B | -$1.54B |
| EBITDA | -$26.00M | $81.00M |
| EPS (basic) | -10.64 | -14.11 |
| EPS (diluted) | -10.64 | -14.11 |
| Weighted avg. shares (diluted) | 109.53M | 109.27M |
| Balance sheet | ||
| Cash & equivalents | $1.26B | $962.00M |
| Receivables | $922.00M | $1.12B |
| Inventory | $2.22B | $2.28B |
| Current assets | $5.69B | $5.13B |
| PP&E, net | $5.08B | $5.27B |
| Goodwill | $4.17B | $5.39B |
| Intangibles | $3.18B | $3.64B |
| Total assets | $21.70B | $22.84B |
| Current liabilities | $3.68B | $3.89B |
| Short-term debt | $1.20B | $1.50B |
| Long-term debt | $11.39B | $11.08B |
| Total debt | $12.60B | $12.58B |
| Total liabilities | $17.22B | $17.27B |
| Shareholders' equity | $4.05B | $5.13B |
| Net debt | $11.34B | $11.62B |
| Shares outstanding | — | 109.33M |
| Cash flow statement | ||
| Operating cash flow | $1.15B | $966.00M |
| Capital expenditure | $343.00M | $435.00M |
| Free cash flow | $803.00M | $531.00M |
| Investing cash flow | -$349.00M | -$470.00M |
| Financing cash flow | -$513.00M | -$1.31B |
| Depreciation & amortization | $760.00M | $801.00M |
| Stock-based compensation | $24.00M | $32.00M |
| Dividends paid | $13.00M | $307.00M |
| Share buybacks | — | $0 |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.